New Step by Step Map For Mouse
All enrolled people who received no less than just one dose of zosuquidar or placebo in the course of induction ended up monitored for the prevalence of adverse situations (439 sufferers, 219 on zosuquidar and 210 on placebo). The commonest adverse situations were connected to the duration of prolonged and considerable myelosuppression as is predic